.png){kind=icon}
.png){kind=icon}
Return
Efficacy and safety of alirocumab once-monthly in patients with atherosclerotic cardiovascular disease and without history of an acute atherothrombotic event
.png){kind=icon}
OA
AI
L
Y
F
K
M
H
M
T
P
M
DOI：10.1016/j.ajpc.2026.101752.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Keywords:
Alirocumab
PCSK9 inhibitor
LDL-cholesterol
Atherosclerotic cardiovascular disease
Once-monthly dosing
Cardiovascular prevention
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
5.9
Papers:
977
Citations:
1.3K
Organization
Cited Papers